Home
About
Overview
Sharing Data
ORCID
Help
History (41)
Gut-Brain Communication in Parkinson's Disease: Enteroendocrine Regulation by GLP-1.
Evaluating Students' Use of Therapeutic Communication in Entry-Level Education: The Observer Version of the Clinical Assessment of Modes (CAM-Observer).
Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients.
The approach to the Jehovah's Witness patient.
The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes.
See All 41 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes.
The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes. Br J Haematol. 2001 Dec; 115(4):881-94.
View in:
PubMed
subject areas
Aged
Case-Control Studies
Cytokines
Endothelial Growth Factors
Female
Hemoglobins
Humans
Immunosuppressive Agents
Lymphokines
Male
Myelodysplastic Syndromes
Platelet Count
Remission Induction
Thalidomide
Transforming Growth Factor alpha
Transforming Growth Factor beta
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors
authors with profiles
Sefer Gezer